Cerus (CERS) EPS (Basic) Growth (3y) (2013 - 2026)
Cerus (CERS) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.01 Bn | 196.41 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.44 Bn | 122.97 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.06 Bn | 73.52 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.70 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.80 Bn | 32.86 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.27 Bn | 22.95 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 17.98% |
| 10 | Cerus | 573.21 Mn | 516.95 Mn | 29.53 Mn | -28.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.38% |
| Mar 31, 2026 | 54.09% |
| Dec 31, 2025 | 48.00% |
| Sep 30, 2025 | 87.06% |
| Jun 30, 2025 | 14.29% |
| Mar 31, 2025 | 16.32% |
| Dec 31, 2024 | -40.33% |
| Sep 30, 2024 | 39.75% |
| Jun 30, 2024 | 29.66% |
| Mar 31, 2024 | 19.86% |
| Dec 31, 2023 | 27.17% |
| Sep 30, 2023 | 22.01% |
| Jun 30, 2023 | 6.56% |
| Mar 31, 2023 | 5.69% |
| Dec 31, 2022 | -61.22% |
| Sep 30, 2022 | 27.76% |
| Jun 30, 2022 | 27.98% |
| Mar 31, 2022 | 19.91% |
| Dec 31, 2021 | 28.48% |
| Sep 30, 2021 | 11.86% |